Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies.
暂无分享,去创建一个
M. Ellis | A. Stead | K. Blackwell | B. Overmoyer | H. Hurwitz | P. Marcom | H. Burris | E. Dees | N. Spector | S. Bacus | A. Dowlati | Deborah A. Smith | K. Koch | B. O'Neil | E. Dees | Lei-hua Liu | W. Xia | Jennifer Harris | T. Bremer | S. Mangum | A. Man | Jennifer L. Harris